Matinas BioPharma

MTNBNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.813 M

$0.28 +5.44%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$10.3M

Loss-making

Shares outstanding

6,406,191

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#496AzitraAZTR$2.19M
#497GenprexGNPX$2.16M
#498Matinas BioPharmaMTNB$1.81M
#499China SXT PharmaceuticalsSXTC$1.74M
#500Clearmind MedicineCMND$1.66M

Where these numbers come from

Share counts and financials for Matinas BioPharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.